BOT 1.33% 37.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-8468

  1. 2,543 Posts.
    lightbulb Created with Sketch. 565
    A number of Biotech e.g. MSB over 1.2bln Market Cap and not FDA on horizon...

    next 2-3 weeks - climb to 40c...45c - starts to sink in..

    Post FDA ..expecting a good run 60-100% - 70 to 80c level...

    Biggest gainers will be 12months after FDA to $2 or $3 based on Sales trajectory...

    Basically : 3% of 3.7mln and 1% of 6.3mln = 174 000 patients - very likely to hit in first 12 -18months...

    174 000 patients by 6 refills by usd 500net Revenue ( after sharing with distributors/ pharma / dermatologists) = Solid usd 520mln Net Revenue

    15x of that is usd 7.8bln or usd 5.2 per share price...


    People whi disagree with Fast rump up - can look at trajectory in Japan and to sleep quite divide my number by 2 and still get usd 2.6 per share...

    Remember refills and Japan still has 70% new patents every year..

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.005(1.33%)
Mkt cap ! $669.7M
Open High Low Value Volume
37.5¢ 39.0¢ 37.0¢ $1.603M 4.223M

Buyers (Bids)

No. Vol. Price($)
4 378157 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 98000 5
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.